Complete Coronary Revascularization and Outcomes in Patients Undergoing CABG: Insights from the REGROUP Trial

There is growing evidence in support of complete coronary revascularization (CR). Nonetheless there is no universally accepted definition of CR in patients undergoing CABG. We sought to investigate the outcomes of CR defined as surgical revascularization of any territory supplied by a suitable coronary artery with at least 50% stenosis. We performed a pre-planned subanalysis of the REGROUP clinical trial cohort. Of 1,147 patients who underwent CABG, 810 (70.6%) received CR. The primary outcome was a composite of major adverse cardiac events (MACE), including death from any cause, nonfatal myocardial infarction (MI), or repeat revascularization over a median 4.7 years of follow-up.
Source: The American Journal of Cardiology - Category: Cardiology Authors: Source Type: research